Logo image of FOSL

FOSSIL GROUP INC (FOSL) Stock Fundamental Analysis

USA - NASDAQ:FOSL - US34988V1061 - Common Stock

2.52 USD
+0.14 (+5.88%)
Last: 10/20/2025, 3:09:36 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to FOSL. FOSL was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and financial health of FOSL have multiple concerns. FOSL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FOSL has reported negative net income.
In the past year FOSL has reported a negative cash flow from operations.
In the past 5 years FOSL reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: FOSL reported negative operating cash flow in multiple years.
FOSL Yearly Net Income VS EBIT VS OCF VS FCFFOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

The Return On Assets of FOSL (-8.44%) is worse than 77.08% of its industry peers.
FOSL has a worse Return On Equity (-39.57%) than 83.33% of its industry peers.
FOSL's Return On Invested Capital of 4.80% is on the low side compared to the rest of the industry. FOSL is outperformed by 64.58% of its industry peers.
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROIC 4.8%
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
FOSL Yearly ROA, ROE, ROICFOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

FOSL's Operating Margin of 2.44% is on the low side compared to the rest of the industry. FOSL is outperformed by 68.75% of its industry peers.
With a decent Gross Margin value of 55.74%, FOSL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of FOSL has remained more or less at the same level.
Industry RankSector Rank
OM 2.44%
PM (TTM) N/A
GM 55.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
FOSL Yearly Profit, Operating, Gross MarginsFOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FOSL is destroying value.
The number of shares outstanding for FOSL has been increased compared to 1 year ago.
Compared to 5 years ago, FOSL has more shares outstanding
Compared to 1 year ago, FOSL has a worse debt to assets ratio.
FOSL Yearly Shares OutstandingFOSL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FOSL Yearly Total Debt VS Total AssetsFOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

FOSL has an Altman-Z score of 1.97. This is not the best score and indicates that FOSL is in the grey zone with still only limited risk for bankruptcy at the moment.
FOSL's Altman-Z score of 1.97 is on the low side compared to the rest of the industry. FOSL is outperformed by 77.08% of its industry peers.
FOSL has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
FOSL has a worse Debt to Equity ratio (1.10) than 72.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.39
WACC12.36%
FOSL Yearly LT Debt VS Equity VS FCFFOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.83 indicates that FOSL should not have too much problems paying its short term obligations.
FOSL has a Current ratio of 1.83. This is comparable to the rest of the industry: FOSL outperforms 45.83% of its industry peers.
FOSL has a Quick Ratio of 1.17. This is a normal value and indicates that FOSL is financially healthy and should not expect problems in meeting its short term obligations.
FOSL has a Quick ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.17
FOSL Yearly Current Assets VS Current LiabilitesFOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2

3. Growth

3.1 Past

FOSL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.39%, which is quite impressive.
Looking at the last year, FOSL shows a very negative growth in Revenue. The Revenue has decreased by -15.34% in the last year.
Measured over the past years, FOSL shows a very negative growth in Revenue. The Revenue has been decreasing by -12.38% on average per year.
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%

3.2 Future

FOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.64% yearly.
The Revenue is expected to decrease by -10.68% on average over the next years. This is quite bad
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
FOSL Yearly Revenue VS EstimatesFOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
FOSL Yearly EPS VS EstimatesFOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2025 2026 2027 0 2 -2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

FOSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FOSL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FOSL Price Earnings VS Forward Price EarningsFOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

FOSL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FOSL is cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.88
FOSL Per share dataFOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

A more expensive valuation may be justified as FOSL's earnings are expected to grow with 29.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.65%
EPS Next 3Y29.64%

0

5. Dividend

5.1 Amount

No dividends for FOSL!.
Industry RankSector Rank
Dividend Yield N/A

FOSSIL GROUP INC

NASDAQ:FOSL (10/20/2025, 3:09:36 PM)

2.52

+0.14 (+5.88%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-05 2025-11-05
Inst Owners48.81%
Inst Owner Change0%
Ins Owners2.05%
Ins Owner Change0.05%
Market Cap135.55M
Analysts82.86
Price Target5.1 (102.38%)
Short Float %9.86%
Short Ratio6.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 0.91
EV/EBITDA 4.88
EPS(TTM)-1.12
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS20.15
BVpS2.79
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.44%
ROE -39.57%
ROCE 6.07%
ROIC 4.8%
ROICexc 6.42%
ROICexgc 6.44%
OM 2.44%
PM (TTM) N/A
GM 55.74%
FCFM N/A
ROA(3y)-11.03%
ROA(5y)-7.54%
ROE(3y)-47.24%
ROE(5y)-31.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.71%
GM growth 5Y1.27%
F-Score3
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 4.1
Cap/Depr 31.55%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.17
Altman-Z 1.97
F-Score3
WACC12.36%
ROIC/WACC0.39
Cap/Depr(3y)47.98%
Cap/Depr(5y)39.78%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.72%
EPS Next Y-101.51%
EPS Next 2Y37.65%
EPS Next 3Y29.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.34%
Revenue growth 3Y-15.08%
Revenue growth 5Y-12.38%
Sales Q2Q%-15.23%
Revenue Next Year-13.86%
Revenue Next 2Y-16.12%
Revenue Next 3Y-10.68%
Revenue Next 5YN/A
EBIT growth 1Y135.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.53%
EBIT Next 3Y52.14%
EBIT Next 5YN/A
FCF growth 1Y-14.84%
FCF growth 3Y0.19%
FCF growth 5YN/A
OCF growth 1Y-53.88%
OCF growth 3Y-2.26%
OCF growth 5YN/A